SG Americas Securities LLC Acquires Shares of 15,658 Medidata Solutions, Inc. (MDSO)
SG Americas Securities LLC acquired a new position in shares of Medidata Solutions, Inc. (NASDAQ:MDSO) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 15,658 shares of the company’s stock, valued at approximately $1,224,000.
A number of other hedge funds have also recently added to or reduced their stakes in MDSO. Acrospire Investment Management LLC bought a new stake in shares of Medidata Solutions during the first quarter worth approximately $121,000. LS Investment Advisors LLC raised its stake in shares of Medidata Solutions by 44.6% in the first quarter. LS Investment Advisors LLC now owns 3,310 shares of the company’s stock worth $191,000 after buying an additional 1,021 shares in the last quarter. World Asset Management Inc bought a new stake in shares of Medidata Solutions during the first quarter worth approximately $201,000. Miles Capital Inc. bought a new stake in shares of Medidata Solutions during the first quarter worth approximately $202,000. Finally, Oppenheimer & Close LLC bought a new stake in shares of Medidata Solutions during the first quarter worth approximately $210,000. Institutional investors and hedge funds own 97.53% of the company’s stock.
Medidata Solutions, Inc. (NASDAQ MDSO) opened at 74.96 on Friday. Medidata Solutions, Inc. has a 12-month low of $46.10 and a 12-month high of $85.92. The company has a 50 day moving average of $75.72 and a 200-day moving average of $68.55. The stock has a market cap of $4.24 billion, a P/E ratio of 121.10 and a beta of 1.79.
Medidata Solutions (NASDAQ:MDSO) last issued its quarterly earnings results on Tuesday, July 18th. The company reported $0.31 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.28 by $0.03. Medidata Solutions had a net margin of 7.07% and a return on equity of 11.14%. The company had revenue of $137.41 million for the quarter, compared to the consensus estimate of $134.28 million. During the same quarter in the prior year, the company earned $0.24 EPS. Medidata Solutions’s quarterly revenue was up 19.9% on a year-over-year basis. Equities analysts forecast that Medidata Solutions, Inc. will post $1.28 earnings per share for the current year.
WARNING: “SG Americas Securities LLC Acquires Shares of 15,658 Medidata Solutions, Inc. (MDSO)” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this article on another website, it was copied illegally and reposted in violation of international copyright legislation. The original version of this article can be read at https://www.thecerbatgem.com/2017/09/01/sg-americas-securities-llc-acquires-shares-of-15658-medidata-solutions-inc-mdso.html.
A number of analysts have recently commented on MDSO shares. Bank of America Corporation started coverage on shares of Medidata Solutions in a research note on Tuesday, June 6th. They issued a “buy” rating and a $85.00 price target for the company. Zacks Investment Research lowered shares of Medidata Solutions from a “hold” rating to a “sell” rating in a research note on Friday, July 21st. BidaskClub upgraded shares of Medidata Solutions from a “hold” rating to a “buy” rating in a research note on Wednesday, June 21st. J P Morgan Chase & Co lifted their price target on shares of Medidata Solutions to $87.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 18th. Finally, Citigroup Inc. reiterated a “buy” rating and issued a $95.00 price target (up from $94.00) on shares of Medidata Solutions in a research note on Monday, July 24th. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and ten have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and an average price target of $80.83.
In related news, Director Robert Taylor sold 5,639 shares of the stock in a transaction that occurred on Monday, June 5th. The shares were sold at an average price of $73.46, for a total value of $414,240.94. Following the transaction, the director now owns 54,372 shares in the company, valued at approximately $3,994,167.12. The sale was disclosed in a filing with the SEC, which is available through this link. Also, COO Michael L. Capone sold 5,000 shares of the stock in a transaction that occurred on Tuesday, August 15th. The stock was sold at an average price of $74.53, for a total transaction of $372,650.00. The disclosure for this sale can be found here. 5.80% of the stock is currently owned by corporate insiders.
About Medidata Solutions
Medidata Solutions Inc (Medidata) is a provider of cloud-based solutions for life sciences. The Company provides cloud-based solutions for clinical research in life sciences, offering platform technology that focuses on the clinical development. The Company’s plan study addresses three areas to ensure optimal study design, grant development and negotiation, and investigator payments.
Want to see what other hedge funds are holding MDSO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Medidata Solutions, Inc. (NASDAQ:MDSO).
Receive News & Stock Ratings for Medidata Solutions Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medidata Solutions Inc. and related stocks with our FREE daily email newsletter.